Persistent ground-glass nodules in the lungs are worth a closer look, as they are highly associated with malignancy. Dr. Anne Leung offered an overview of how these lesions present on CT imaging at the 2008 Stanford International Symposium on Multidetector-Row CT in Las Vegas.
Persistent ground-glass nodules in the lungs are worth a closer look, as they are highly associated with malignancy. Dr. Anne Leung offered an overview of how these lesions present on CT imaging at the 2008 Stanford International Symposium on Multidetector-Row CT in Las Vegas. "Ground glass is defined as hazy or decreased attenuation on CT that does not obscure underlying bronchovascular bundles," said Leung, chief of thoracic imaging at Stanford University School of Medicine. "The pathologic correlates that have been described with ground-glass nodules are partial airspace filling, interstitial filling, edema, fibrosis, and neoplastic infiltration." Leung pointed out that ground-glass nodules have two subtypes: pure ground glass and ground glass with solid components. Ground-glass nodules with solid elements are more likely to be malignant, particularly if they persist over three months, she said.
Leung highlighted some of the differential diagnoses that can be made on CT when ground-glass nodules are present:
Among the primary neoplastic diseases, she described atypical edematous hyperplasia. The CT features of these peripheral lesions are a size of less than 5 mm, round or oval shape, smooth margins, and pure ground-glass appearance.
Focal ground-glass nodules with solid components are also found with bronchoalveolar cell carcinoma. Other CT features to look for are air lucencies, smooth or irregular contours, and slow growth, Leung said. Finally, there is adenocarcinoma, the most common lung cancer in the U.S. CT features of this disease state are focal ground-glass nodules with solid elements, air lucencies, and smooth or irregular contours. Leung concluded that persistent ground-glass nodules are best seen with thin-section imaging. Readers should keep an eye out for solid components and interval growth. Finally, she recommended against evaluating ground-glass nodules with PET studies, as negative results are generally not a reliable indicator of benign disease.
New Analysis Forecasts Substantial Cost Savings with the Use of Photon Counting CT for CCTA
March 8th 2025The use of ultra-high-resolution photon-counting CT in the evaluation of stable chest pain may significantly reduce follow-up tests and invasive coronary angiography (ICA) procedures, possibly resulting in millions in health-care cost savings, according to a cost-effectiveness analysis presented recently at the European Congress of Radiology.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Can CT-Based AI Help Predict Renal Function Decline After Radioligand Therapy for mCRPC?
February 25th 2025In patients who had at least four cycles of 177Lu-PSMA-I&T for mCRPC, new research shows that a 10 percent or greater decrease in total kidney volume on CT at six months has a 90 percent AUC for predicting estimated glomerular filtration rates (eGFRs) of 30 percent or greater at one year.